136 related articles for article (PubMed ID: 16397025)
1. Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection.
Soussi T; Asselain B; Hamroun D; Kato S; Ishioka C; Claustres M; Béroud C
Clin Cancer Res; 2006 Jan; 12(1):62-9. PubMed ID: 16397025
[TBL] [Abstract][Full Text] [Related]
2. The UMD-p53 database: new mutations and analysis tools.
Béroud C; Soussi T
Hum Mutat; 2003 Mar; 21(3):176-81. PubMed ID: 12619103
[TBL] [Abstract][Full Text] [Related]
3. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
Petitjean A; Mathe E; Kato S; Ishioka C; Tavtigian SV; Hainaut P; Olivier M
Hum Mutat; 2007 Jun; 28(6):622-9. PubMed ID: 17311302
[TBL] [Abstract][Full Text] [Related]
4. IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer.
Hernandez-Boussard T; Rodriguez-Tome P; Montesano R; Hainaut P
Hum Mutat; 1999; 14(1):1-8. PubMed ID: 10447253
[TBL] [Abstract][Full Text] [Related]
5. MUT-TP53 2.0: a novel versatile matrix for statistical analysis of TP53 mutations in human cancer.
Soussi T; Hamroun D; Hjortsberg L; Rubio-Nevado JM; Fournier JL; Béroud C
Hum Mutat; 2010 Sep; 31(9):1020-5. PubMed ID: 20572016
[TBL] [Abstract][Full Text] [Related]
6. The UMD TP53 database and website: update and revisions.
Hamroun D; Kato S; Ishioka C; Claustres M; Béroud C; Soussi T
Hum Mutat; 2006 Jan; 27(1):14-20. PubMed ID: 16278824
[TBL] [Abstract][Full Text] [Related]
7. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.
Petitjean A; Achatz MI; Borresen-Dale AL; Hainaut P; Olivier M
Oncogene; 2007 Apr; 26(15):2157-65. PubMed ID: 17401424
[TBL] [Abstract][Full Text] [Related]
8. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis.
Soussi T; Dehouche K; Béroud C
Hum Mutat; 2000; 15(1):105-13. PubMed ID: 10612830
[TBL] [Abstract][Full Text] [Related]
9. UMD (Universal mutation database): a generic software to build and analyze locus-specific databases.
Béroud C; Collod-Béroud G; Boileau C; Soussi T; Junien C
Hum Mutat; 2000; 15(1):86-94. PubMed ID: 10612827
[TBL] [Abstract][Full Text] [Related]
10. Methylation and repeats in silent and nonsense mutations of p53.
Kouidou S; Malousi A; Maglaveras N
Mutat Res; 2006 Jul; 599(1-2):167-77. PubMed ID: 16620878
[TBL] [Abstract][Full Text] [Related]
11. TP53 mutations in human cancer: database reassessment and prospects for the next decade.
Soussi T
Adv Cancer Res; 2011; 110():107-39. PubMed ID: 21704230
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations.
Soussi T; Kato S; Levy PP; Ishioka C
Hum Mutat; 2005 Jan; 25(1):6-17. PubMed ID: 15580553
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
14. In silico p53 mutation hotspots in lung cancer.
Lewis PD; Parry JM
Carcinogenesis; 2004 Jul; 25(7):1099-107. PubMed ID: 14729588
[TBL] [Abstract][Full Text] [Related]
15. Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers.
Lamolle G; Marin M; Alvarez-Valin F
Mutat Res; 2006 Aug; 600(1-2):102-12. PubMed ID: 16650445
[TBL] [Abstract][Full Text] [Related]
16. Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation.
Wu XM; Fu JG; Ge WZ; Zhu JY; Wang JY; Zhang W; Qian W; Huo KK
J Zhejiang Univ Sci B; 2007 Feb; 8(2):81-7. PubMed ID: 17266182
[TBL] [Abstract][Full Text] [Related]
17. Predicting the transactivation activity of p53 missense mutants using a four-body potential score derived from Delaunay tessellations.
Mathe E; Olivier M; Kato S; Ishioka C; Vaisman I; Hainaut P
Hum Mutat; 2006 Feb; 27(2):163-72. PubMed ID: 16395672
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53: an oncogenic transcription factor.
Strano S; Dell'Orso S; Di Agostino S; Fontemaggi G; Sacchi A; Blandino G
Oncogene; 2007 Apr; 26(15):2212-9. PubMed ID: 17401430
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of mutant p53: molecular mechanisms and therapeutic potential.
Selivanova G; Wiman KG
Oncogene; 2007 Apr; 26(15):2243-54. PubMed ID: 17401433
[TBL] [Abstract][Full Text] [Related]
20. p53 alterations in human cancer: more questions than answers.
Soussi T
Oncogene; 2007 Apr; 26(15):2145-56. PubMed ID: 17401423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
